Kronos Bio
We’re focused on creating a world where no life is cut short by cancer or other serious diseases.
70 employees · est. 2017 · San Mateo, United States
Rubius Therapeutics
Red blood cells are no longer just for carrying oxygen. At Rubius Therapeutics, we are transforming them into medicines.
18 employees · est. 2014 · Cambridge, United States
Rubius Therapeutics is the older company (2017 vs 2014); Kronos Bio is the larger of the two.
Side-by-Side Comparison
| Metric | Kronos Bio | Rubius Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2014 older |
| Headquarters | ||
| Headquarters | San Mateo, United States | Cambridge, United States |
| Employees | ||
| Employees | 70 larger | 18 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness | Biotechnology |
| Funding Stage | ||
| Funding Stage | Private Equity | IPO |
| Total Funding | ||
| Total Funding | $278.00M | $686.00M |
| Funding Rounds | ||
| Funding Rounds | 3 | 6 |
| Services | ||
| Services | Not tracked yet | real money casino gaming, casino reviews and comparisons, bonus offers and promotions, secure payment processing, VIP club management |
| Target Customers | ||
| Target Customers | Not tracked yet | Australian casino players, jackpot seekers, mobile casino users, crypto gamblers |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical Company, Clinical-stage, Therapeutics, CDK9 Inhibitor, Transcription Factor, Oncology, Cancer Treatment, Myc-dependent Tumors, Transcriptional Addiction, Discovery Collaboration, Genentech Partnership, P300 KAT Domain, Multiple Myeloma, Transcriptional Targets, Precision Medicine | Biopharmaceutical Company, Cellular Medicines, Genetic Engineering, Red Cell Therapeutics, Oncology, Autoimmune Diseases, Cell-cell Interaction, Tolerance Induction, Phase 1/2 Clinical Trial, Advanced Solid Tumors, RTX-240, RTX-224, Non-small Cell Lung Cancer, Renal Cell Carcinoma, Combination Therapy |
| Website | ||
| Website | kronosbio.com | rubiustx.com |
About Kronos Bio
Kronos Bio is a clinical-stage biopharmaceutical company with a mission to combat cancer and serious diseases by targeting dysregulated transcription. The company's current pipeline includes KB-0742, a CDK9 inhibitor under evaluation for MYC-dependent tumors and KB-9558, targeting the KAT domain of...
About Rubius Therapeutics
Rubius Therapeutics, founded in 2014 and headquartered in the United States, is at the forefront of biotechnology by innovatively repurposing red blood cells as medicines. With their slogan, "Red blood cells are no longer just for carrying oxygen. At Rubius Therapeutics, we are transforming them int...
We will tell you when either one moves
BounceWatch watches Kronos Bio and Rubius Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Kronos Bio and Rubius Therapeutics — by email.
Frequently Asked Questions
Compare Kronos Bio with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Kronos Bio on 12 Sep 2024, and Rubius Therapeutics on 10 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.